Bangkok Chain Hospital Public Company Limited - Depositary Receipt (Common Stock) - Income Statement (TTM)

Bangkok Chain Hospital Public Company Limited - Depositary Receipt (Common Stock)
TH ˙ SET ˙ TH0808010R14
Income Statement (TTM)

Bangkok Chain Hospital Public Company Limited - Depositary Receipt (Common Stock) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8,896 9,014 9,201 11,429 17,031 21,529 26,265 27,476 22,952 18,910 14,488 11,819 11,561 11,830 11,999 12,006 12,095 11,832 11,896 12,062
Change (%) 1.33 2.07 24.22 49.01 26.41 21.99 4.61 -16.47 -17.61 -23.39 -18.42 -2.18 2.33 1.43 0.06 0.74 -2.17 0.54 1.39
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,939 5,975 6,078 7,005 9,197 10,561 12,832 14,001 13,831 12,772 10,817 9,319 7,898 8,116 8,224 8,347 8,487 8,527 8,571 8,570
Change (%) 0.60 1.74 15.24 31.30 14.83 21.50 9.10 -1.21 -7.66 -15.30 -13.85 -15.25 2.75 1.33 1.51 1.68 0.47 0.52 -0.01
% of Revenue 66.76 66.28 66.06 61.29 54.00 49.06 48.86 50.96 60.26 67.54 74.67 78.85 68.32 68.60 68.53 69.52 70.17 72.06 72.05 71.05
Gross Operating Profit 2,957 3,040 3,123 4,424 7,834 10,968 13,432 13,476 9,121 6,139 3,670 2,499 3,662 3,714 3,776 3,659 3,607 3,306 3,325 3,492
Change (%) 2.79 2.73 41.68 77.05 40.01 22.47 0.32 -32.31 -32.70 -40.21 -31.90 46.53 1.42 1.65 -3.09 -1.41 -8.37 0.59 5.01
% of Revenue 33.24 33.72 33.94 38.71 46.00 50.94 51.14 49.04 39.74 32.46 25.33 21.15 31.68 31.40 31.47 30.48 29.83 27.94 27.95 28.95
SG&A 1,169 1,213 1,210 1,331 1,422 1,469 1,670 1,793 1,846 1,946 1,853 1,824 1,874 1,755 1,733 1,625 1,572 1,595 1,594 1,608
Change (%) 3.71 -0.21 9.98 6.83 3.34 13.64 7.37 2.98 5.40 -4.79 -1.53 2.71 -6.35 -1.26 -6.21 -3.27 1.44 -0.01 0.87
% of Revenue 13.15 13.45 13.15 11.65 8.35 6.82 6.36 6.52 8.04 10.29 12.79 15.44 16.21 14.83 14.44 13.54 13.00 13.48 13.40 13.33
R&D
Change (%)
% of Revenue
OpEx 7,108 7,187 7,289 8,336 10,619 12,031 14,502 15,793 15,677 14,717 12,670 11,144 9,772 9,870 9,956 9,973 10,059 10,122 10,165 10,179
Change (%) 1.12 1.41 14.37 27.39 13.29 20.54 8.90 -0.74 -6.12 -13.91 -12.05 -12.31 1.01 0.87 0.16 0.87 0.62 0.43 0.13
% of Revenue 79.90 79.73 79.21 72.93 62.35 55.88 55.21 57.48 68.30 77.83 87.45 94.29 84.53 83.44 82.97 83.06 83.17 85.54 85.45 84.39
Operating Income 1,788 1,827 1,913 3,093 6,412 9,499 11,763 11,683 7,275 4,193 1,818 675 1,789 1,959 2,043 2,034 2,035 1,711 1,731 1,883
Change (%) 2.19 4.68 61.75 107.27 48.15 23.83 -0.68 -37.73 -42.36 -56.65 -62.86 164.96 9.56 4.26 -0.45 0.08 -15.95 1.15 8.82
% of Revenue 20.10 20.27 20.79 27.07 37.65 44.12 44.79 42.52 31.70 22.17 12.55 5.71 15.47 16.56 17.03 16.94 16.83 14.46 14.55 15.61
Interest Expense -127 -132 -130 -132 -138 -151 -172 -175 -170 -156 -135 -121 -117 -95 -79 -67 -52 -55 -58 -60
Change (%) 4.43 -1.82 2.06 4.14 9.72 13.51 2.04 -2.96 -8.39 -13.09 -10.56 -3.74 -18.20 -17.23 -14.72 -22.55 4.76 7.15 2.77
% of Revenue -1.42 -1.47 -1.41 -1.16 -0.81 -0.70 -0.65 -0.64 -0.74 -0.82 -0.93 -1.02 -1.01 -0.81 -0.66 -0.56 -0.43 -0.46 -0.49 -0.50
Net Income 1,192 1,229 1,294 2,161 4,644 6,846 8,551 8,549 5,249 3,039 1,264 405 1,249 1,406 1,471 1,464 1,477 1,282 1,285 1,396
Change (%) 3.14 5.26 67.01 114.89 47.41 24.90 -0.02 -38.59 -42.11 -58.39 -67.99 208.44 12.64 4.62 -0.49 0.86 -13.17 0.19 8.65
% of Revenue 13.40 13.64 14.06 18.91 27.27 31.80 32.56 31.11 22.87 16.07 8.73 3.43 10.80 11.89 12.26 12.19 12.21 10.84 10.80 11.57

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista